Literature DB >> 21311342

Unifying cancer genetics.

Sharon E Plon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21311342      PMCID： PMC3412587          DOI： 10.1097/GIM.0b013e31820d5e87

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  14 in total

1.  Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations.

Authors:  Maria C Curia; Michele Zuckermann; Laura De Lellis; Teresa Catalano; Rossano Lattanzio; Gitana Aceto; Serena Veschi; Alessandro Cama; Jean-Bernard Otte; Mauro Piantelli; Renato Mariani-Costantini; Francesco Cetta; Pasquale Battista
Journal:  Mod Pathol       Date:  2007-10-26       Impact factor: 7.842

2.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

Review 3.  Anaplastic lymphoma kinase as a therapeutic target in anaplastic large cell lymphoma, non-small cell lung cancer and neuroblastoma.

Authors:  Mangeng Cheng; Gregory R Ott
Journal:  Anticancer Agents Med Chem       Date:  2010-03       Impact factor: 2.505

4.  Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?

Authors:  Stefan Aretz; Arend Koch; Siegfried Uhlhaas; Waltraut Friedl; Peter Propping; Dietrich von Schweinitz; Torsten Pietsch
Journal:  Pediatr Blood Cancer       Date:  2006-11       Impact factor: 3.167

Review 5.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

Authors:  Henry T Lynch; Jane F Lynch; Patrick M Lynch; Thomas Attard
Journal:  Fam Cancer       Date:  2007-11-13       Impact factor: 2.375

6.  Detection of mosaic RB1 mutations in families with retinoblastoma.

Authors:  Diane Rushlow; Beata Piovesan; Katherine Zhang; Nadia L Prigoda-Lee; Mellone N Marchong; Robin D Clark; Brenda L Gallie
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

7.  Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model.

Authors:  C Armengol; S Cairo; M Fabre; M A Buendia
Journal:  Int J Biochem Cell Biol       Date:  2009-07-29       Impact factor: 5.085

8.  Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.

Authors:  Dolores López-Terrada; Preethi H Gunaratne; Adekunle M Adesina; Joseph Pulliam; David M Hoang; Yummy Nguyen; Toni-Ann Mistretta; Judith Margolin; Milton J Finegold
Journal:  Hum Pathol       Date:  2009-02-05       Impact factor: 3.466

Review 9.  The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Curr Opin Genet Dev       Date:  2009-05-19       Impact factor: 5.578

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962
View more
  1 in total

Review 1.  Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.

Authors:  Muin J Khoury; Steven B Clauser; Andrew N Freedman; Elizabeth M Gillanders; Russ E Glasgow; William M P Klein; Sheri D Schully
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-27       Impact factor: 4.254
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.